<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03403972</url>
  </required_header>
  <id_info>
    <org_study_id>MBSVT_PK</org_study_id>
    <nct_id>NCT03403972</nct_id>
  </id_info>
  <brief_title>Evaluate the Effects of the Environmental Change in Intestine by Antibiotics on the Pharmacokinetic Characteristics of Simvastatin in Healthy Male Volunteers</brief_title>
  <official_title>A Clinical Trial to Evaluate the Effects of the Environmental Change in Intestine by Antibiotics on the Pharmacokinetic Characteristics of Simvastatin in Healthy Male Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This phase 1 clinical trial is to evaluate the effects of the environmental change in
      intestine by antibiotics on the pharmacokinetic characteristics of simvastatin in healthy
      male volunteers. For change of intestine environment, especially the gut microbiota,
      investigators will administer PO vancomycin for 7 days, tid.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 6, 2017</start_date>
  <completion_date type="Actual">January 11, 2018</completion_date>
  <primary_completion_date type="Actual">January 11, 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare the maximum plasma concentration (Cmax)</measure>
    <time_frame>vancomycin PO will administered for 7 days</time_frame>
    <description>Compare the maximum plasma concentration (Cmax) of simvastatin before and after vancomycin PO treatment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Compare the area under the time-plasma concentration curve (AUC)</measure>
    <time_frame>vancomycin PO will administered for 7 days</time_frame>
    <description>Compare the area under the time-plasma concentration curve (AUC) of simvastatin before and after vancomycin PO treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Explore the gut microbiome species change</measure>
    <time_frame>vancomycin PO will administered for 7 days</time_frame>
    <description>Explore how the gut microbiome species change after vancomycin multiple dosing for 7 days</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Simvastatin Pharmacokinetics and Gut Microbiome</condition>
  <arm_group>
    <arm_group_label>Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: vancomycin 500 mg tid for 7 days (Vancozin 250 mg capsule)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vancomycin 250Mg Capsule</intervention_name>
    <description>Investigators will compare simavastatin pharmacokinetics before and after the vancomycin PO multiple administration.</description>
    <arm_group_label>Group</arm_group_label>
    <other_name>simvastatin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 19 Y to 50 Y at the screening

          -  Body weight over 55 kg and BMI should be between 18.0 to 25.0 kg/m2

          -  Informed consent will be taken before all the procedures from volunteers

          -  SLCO1B1 genotype is *1/*1 when screening

        Exclusion Criteria:

          -  No significant disease history or ongoing disease

          -  Allergic to simvastatin and vancomycin, or similar affiliation drug for simvastatin or
             vancomycin

          -  MDRD eGFR less than 60 mL/min/1.73m2

          -  Total cholesterol, LDL, TG is higher than 1.5 times more than upper normal limit at
             the screening

          -  HDL less than 35 mg/dL at the screening

          -  Positive HBV or HIV or HCV

          -  Who is administering or going to administer CYP3A4 inihibitor drug

          -  Other clinically significant situation under doctor's opinion
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SeungHwan Lee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital Clinical Trial Center</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2017</study_first_submitted>
  <study_first_submitted_qc>January 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 19, 2018</study_first_posted>
  <last_update_submitted>January 18, 2018</last_update_submitted>
  <last_update_submitted_qc>January 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>SeungHwan Lee</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>pharmacokinetics</keyword>
  <keyword>simvastatin</keyword>
  <keyword>vancomycin</keyword>
  <keyword>gut microbiome</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Vancomycin</mesh_term>
    <mesh_term>Simvastatin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Investigators have no plan to share individual participant data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

